NEWYORK-PRESBYTERIAN/QUEENS
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $2.9M
- Transactions
- 564
- Companies
- 40
- Average per transaction
- $5,075
Who reported the payments
| Gilead | $923,731 |
| Novartis | $447,102 |
| Boston Scientific | $214,415 |
| Surgical Theater. Inc. | $144,000 |
| Merck | $140,268 |
| Novocure Inc. | $135,564 |
| Abbott | $96,097 |
| Volta Medical Inc | $84,848 |
| Biotronik Inc. | $82,157 |
| Endotronix, Inc. | $80,311 |
| Chiesi USA, Inc. | $60,337 |
| Janssen Research & Development, LLC | $56,196 |
| Stryker | $39,880 |
| Aesculap, Inc. | $36,181 |
| Olympus America Inc. | $36,081 |
| Pfizer | $31,209 |
| Regeneron | $26,113 |
| Pacira Therapeutics, Inc. | $24,113 |
| Sanofi US Services Inc. | $20,500 |
| Siemens Medical Solutions USA, Inc. | $16,683 |
| Swedish Orphan Biovitrum AB | $15,966 |
| Linvatec Corporation | $14,155 |
| Johnson & Johnson | $13,767 |
| Bio-rad Laboratories, Inc. | $13,449 |
| Masimo Corporation | $12,395 |
| AstraZeneca | $11,835 |
| Medline Industries LP | $9,625 |
| Genentech USA, Inc. | $7,000 |
| Alcresta Therapeutics, Inc. | $6,500 |
| Lantheus Medical Imaging, Inc. | $6,000 |
| Bausch Health US, LLC | $6,000 |
| Humacyte Global, Inc. | $5,617 |
| Boehringer Ingelheim | $5,000 |
| Edwards Lifesciences | $4,250 |
| Cvrx, Inc. | $3,985 |
| Smith+Nephew | $3,606 |
| Suvon Surgical LLC | $3,000 |
| Baxter Healthcare | $2,955 |
| Penumbra, Inc. | $2,500 |
| Biosense Webster, Inc. | $2,500 |